Skip to main content
. 2012 Oct 25;7:5565–5575. doi: 10.2147/IJN.S36939

Figure 10.

Figure 10

Serum concentration-time profile of fenofibrate in rats after oral administration of the raw fenofibrate, the commercial product (Lipidi Supra®), and the prepared powder (SC3) at a dose equivalent to 50 mg of fenofibrate/kg of bodyweight.

Note: Data are expressed as the mean ± standard deviation (n = 5).

Abbreviation: SC3, supercritical method 3 (fenofibrate:Neusilin UFL2 = 40:60).